208 related articles for article (PubMed ID: 17591831)
21. Development and biological evaluation of a novel aurora A kinase inhibitor.
Sardon T; Cottin T; Xu J; Giannis A; Vernos I
Chembiochem; 2009 Feb; 10(3):464-78. PubMed ID: 19199284
[TBL] [Abstract][Full Text] [Related]
22. A pharmacodynamic model of Aurora kinase inhibitors in the spindle assembly checkpoint.
Mistry HB; MacCallum DE; Jackson RC; Chaplain MA; Davidson FA
Front Biosci (Landmark Ed); 2010 Jan; 15(1):249-58. PubMed ID: 20036819
[TBL] [Abstract][Full Text] [Related]
23. Aurora A: target invalidated?
Cochran AG
Chem Biol; 2008 Jun; 15(6):525-6. PubMed ID: 18559262
[TBL] [Abstract][Full Text] [Related]
24. Aurora kinase A inhibitors: promising agents in antitumoral therapy.
Malumbres M; PĂ©rez de Castro I
Expert Opin Ther Targets; 2014 Dec; 18(12):1377-93. PubMed ID: 25200357
[TBL] [Abstract][Full Text] [Related]
25. Progress in the development of selective inhibitors of Aurora kinases.
Mortlock A; Keen NJ; Jung FH; Heron NM; Foote KM; Wilkinson R; Green S
Curr Top Med Chem; 2005; 5(2):199-213. PubMed ID: 15853647
[TBL] [Abstract][Full Text] [Related]
26. Aurora kinase family: a new target for anticancer drug.
Macarulla T; Ramos FJ; Tabernero J
Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):114-22. PubMed ID: 18537754
[TBL] [Abstract][Full Text] [Related]
27. Aurora kinase inhibitors.
Kitzen JJ; de Jonge MJ; Verweij J
Crit Rev Oncol Hematol; 2010 Feb; 73(2):99-110. PubMed ID: 19369091
[TBL] [Abstract][Full Text] [Related]
28. Aurora kinases as targets for cancer therapy.
Mountzios G; Terpos E; Dimopoulos MA
Cancer Treat Rev; 2008 Apr; 34(2):175-82. PubMed ID: 18023292
[TBL] [Abstract][Full Text] [Related]
29. Aurora kinases: novel therapy targets in cancers.
Tang A; Gao K; Chu L; Zhang R; Yang J; Zheng J
Oncotarget; 2017 Apr; 8(14):23937-23954. PubMed ID: 28147341
[TBL] [Abstract][Full Text] [Related]
30. Aurora kinase inhibitor patents and agents in clinical testing: an update (2011 - 2013).
Cheung CH; Sarvagalla S; Lee JY; Huang YC; Coumar MS
Expert Opin Ther Pat; 2014 Sep; 24(9):1021-38. PubMed ID: 24965505
[TBL] [Abstract][Full Text] [Related]
31. Small-molecule inhibition of Aurora kinases triggers spindle checkpoint-independent apoptosis in cancer cells.
Sun L; Li D; Dong X; Yu H; Dong JT; Zhang C; Lu X; Zhou J
Biochem Pharmacol; 2008 Mar; 75(5):1027-34. PubMed ID: 18163976
[TBL] [Abstract][Full Text] [Related]
32. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol.
Anand S; Penrhyn-Lowe S; Venkitaraman AR
Cancer Cell; 2003 Jan; 3(1):51-62. PubMed ID: 12559175
[TBL] [Abstract][Full Text] [Related]
33. Antimitotic inhibitors.
Campos SM; Dizon DS
Hematol Oncol Clin North Am; 2012 Jun; 26(3):607-28, viii-ix. PubMed ID: 22520982
[TBL] [Abstract][Full Text] [Related]
34. Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe.
Li J; Hong MJ; Chow JP; Man WY; Mak JP; Ma HT; Poon RY
Oncotarget; 2015 Apr; 6(11):9327-40. PubMed ID: 25871386
[TBL] [Abstract][Full Text] [Related]
35. Mitotic drivers--inhibitors of the Aurora B Kinase.
Keen N; Taylor S
Cancer Metastasis Rev; 2009 Jun; 28(1-2):185-95. PubMed ID: 19189202
[TBL] [Abstract][Full Text] [Related]
36. Selective aurora kinase inhibitors identified using a taxol-induced checkpoint sensitivity screen.
Kwiatkowski N; Deng X; Wang J; Tan L; Villa F; Santaguida S; Huang HC; Mitchison T; Musacchio A; Gray N
ACS Chem Biol; 2012 Jan; 7(1):185-96. PubMed ID: 21992004
[TBL] [Abstract][Full Text] [Related]
37. Kinome-wide siRNA screening identifies molecular targets mediating the sensitivity of pancreatic cancer cells to Aurora kinase inhibitors.
Xie L; Kassner M; Munoz RM; Que QQ; Kiefer J; Zhao Y; Mousses S; Yin HH; Von Hoff DD; Han H
Biochem Pharmacol; 2012 Feb; 83(4):452-61. PubMed ID: 22100984
[TBL] [Abstract][Full Text] [Related]
38. Danusertib, an aurora kinase inhibitor.
Meulenbeld HJ; Mathijssen RH; Verweij J; de Wit R; de Jonge MJ
Expert Opin Investig Drugs; 2012 Mar; 21(3):383-93. PubMed ID: 22242557
[TBL] [Abstract][Full Text] [Related]
39. Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores.
Ditchfield C; Johnson VL; Tighe A; Ellston R; Haworth C; Johnson T; Mortlock A; Keen N; Taylor SS
J Cell Biol; 2003 Apr; 161(2):267-80. PubMed ID: 12719470
[TBL] [Abstract][Full Text] [Related]
40. Clinical experience with aurora kinase inhibitors: a review.
Boss DS; Beijnen JH; Schellens JH
Oncologist; 2009 Aug; 14(8):780-93. PubMed ID: 19684075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]